Mr. Israel Makov
Mr Israel Makov is Chairman Biolight, a leading ophthalmic company investing in companies and managing projects in the field of eye diseases and ocular treatments. He is also Chairman of QuantalX Neuroscience, a company developing Direct Electro-Physiological Imaging (DELPHI) for early, precise, and objective evaluation of brain function and Chairman of Nextage Therapeutics, a pharma company that develops next-generation cannabinoid-based products.
Mr Makov is the former Chairman of Sun Pharma - the world’s 4th largest specialty generic pharma company and the largest pharma company in India, former Chairman of Given Imaging - the developer and world’s leading provider of capsule endoscopy and Netafim - the pioneer and global leader in smart irrigation solutions.
Mr. Makov is also the former President & CEO of Teva Pharmaceutical Industries Ltd. He led the company’s global expansion and under his leadership Teva became the undisputed global leader in the generic pharmaceutical industry and a global leader in the treatment of Multiple sclerosis.
Mr Makov is a member of the Executive Board & Management Committee of the Weizmann Institute of Science, a Director at Yeda Research and Development Company Ltd and on the Board of Governors of the Technion – Israel Institute of Technology. Mr. Makov is also Chairman of the Gesher Theatre, one of Israel’s leading theatres.